Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2011, Article ID 738131, 8 pages
http://dx.doi.org/10.1093/ecam/nen072
Original Article

Mumijo Traditional Medicine: Fossil Deposits from Antarctica (Chemical Composition and Beneficial Bioactivity)

1Dipartimento di Chimica delle Sostanze Naturali, Università di Napoli “Federico II”, via D. Montesano 49, 80131 Napoli, Italy
2Abteilung für Angewandte Molekularbiologie, Institut für Physiologische Chemie, Johannes Gutenberg-Universität Mainz, Duesbergweg 6, 55099 Mainz, Germany

Received 8 July 2008; Accepted 10 October 2008

Copyright © 2011 Anna Aiello et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Aristotle, “Aristotelis Opera ex recensione Immanuelis Bekkeri,” in Index Aristotelicus. Berlin, 1870, H. Bonitz, Ed., pp. 223–259, de Gruyter, Berlin, Germany, 1961. View at Google Scholar
  2. W. E. G. Müller, R. Batel, H. C. Schröder, and I. M. Müller, “Traditional and modern biomedical prospecting: I. The history. Sustainable exploitation of biodiversity (sponges and invertebrates) in the Adriatic Sea at Rovinj (Croatia),” Evidence-Based Complementary and Alternative Medicine, vol. 1, pp. 71–82, 2004. View at Google Scholar
  3. A. Garedew, M. Feist, E. Schmolz, and I. Lamprecht, “Thermal analysis of mumiyo, the legendary folk remedy from the Himalaya region,” Thermochimica Acta, vol. 417, no. 2, pp. 301–309, 2004. View at Publisher · View at Google Scholar
  4. H. Haeser and A. Middeldorph, Eds., Pfolsprundt H v Buch der Bündt-Ertznei [1460], Georg Reimer, Berlin, Germany, 1868.
  5. L. N. Frolova and T. L. Kiseleva, “Structure of chemical compounds, methods of analysis and process control: chemical composition of Mumijo and methods for determining its authenticity and quality,” Pharmaceutical Chemistry Journal, vol. 30, pp. 543–547, 1996. View at Google Scholar
  6. I. A. Schepetkin, A. I. Khlebnikov, S. Y. Ah et al., “Characterization and biological activities of humic substances from mumie,” Journal of Agricultural and Food Chemistry, vol. 51, no. 18, pp. 5245–5254, 2003. View at Publisher · View at Google Scholar · View at PubMed
  7. V. Spassov, “Memory effects of the natural product Mumyo on the water maze in rats,” European Neuropsychopharmacology, vol. 4, no. 3, p. 396, 1994. View at Google Scholar
  8. A. Hiller, W.-D. Hermichen, and U. Wand, “Radiocarbon-dated subfossil stomach oil deposits from petrel nesting sites: novel paleoenvironmental records from continental Antarctica,” Radiocarbon, vol. 37, no. 2, pp. 171–180, 1995. View at Google Scholar
  9. J. Warham, R. Watts, and R. J. Dainty, “The composition, energy content and function of the stomach oils of petrels (order, procellariiformes),” Journal of Experimental Marine Biology and Ecology, vol. 23, no. 1, pp. 1–13, 1976. View at Google Scholar
  10. R. W. Lewis, “Studies of the glyceryl ethers of the stomach oil of Leach's petrel Oceanodroma leucorhoa (Viellot),” Comparative Biochemistry and Physiology, vol. 19, no. 2, pp. 363–377, 1966. View at Google Scholar
  11. A. R. Place, N. C. Stoyan, R. E. Rickleps, and R. G. Butler, “Physiological basis of stomach oil formation in Leach's storm-petrel (Oceanodroma leucorhoa),” The Auk, vol. 106, pp. 687–699, 1989. View at Google Scholar
  12. J. Warham, “The incidence, function and ecological significance of petrel stomach oils,” Proceedings of the New Zealand Ecological Society, vol. 24, pp. 84–93, 1977. View at Google Scholar
  13. A. Hiller, U. Wand, H. Kämpf, and W. Stackebrandt, “Occupation of the Antarctic continent by petrels during the past 35 000 years: inferences from a 14C study of stomach oil deposits,” Polar Biology, vol. 9, no. 2, pp. 69–77, 1988. View at Publisher · View at Google Scholar
  14. S. R. Verkulich and A. Hiller, “Holocene deglaciation of the Bunger Hills revealed by 14C measurements on stomach oil deposits in snow petrel colonies,” Antarctic Science, vol. 6, no. 3, pp. 395–399, 1994. View at Google Scholar
  15. U. Lindequist, T. H. J. Niedermeyer, and W.-D. Jülich, “The pharmacological potential of mushrooms,” Evidence-Based Complementary and Alternative Medicine, vol. 2, no. 3, pp. 285–299, 2005. View at Publisher · View at Google Scholar · View at PubMed
  16. M. Shimazawa, S. Chikamatsu, N. Morimoto, S. Mishima, H. Nagai, and H. Hara, “Neuroprotection by Brazilian green propolis against in vitro and in vivo ischemic neuronal damage,” Evidence-Based Complementary and Alternative Medicine, vol. 2, no. 2, pp. 201–207, 2005. View at Publisher · View at Google Scholar · View at PubMed
  17. K Terasawa, “Evidence-based reconstruction of Kampo medicine: part I—is Kampo CAM?” Evidence-Based Complementary and Alternative Medicine, vol. 1, pp. 11–16, 2004. View at Publisher · View at Google Scholar · View at PubMed
  18. B. Saad, H. Azaizeh, and O. Said, “Tradition and perspectives of Arab herbal medicine: a review,” Evidence-Based Complementary and Alternative Medicine, vol. 2, no. 4, pp. 475–479, 2005. View at Publisher · View at Google Scholar · View at PubMed
  19. W. E. G. Müller, H. C. Schroder, H. Ushijima, J. Dapper, and J. Bormann, “gp120 of HIV-1 induces apoptosis in rat cortical cell cultures: prevention by memantine,” European Journal of Pharmacology, vol. 226, no. 3, pp. 209–214, 1992. View at Publisher · View at Google Scholar
  20. S. Perovic, C. Schleger, G. Pergande et al., “The triaminopyridine flupirtine prevents cell death in rat cortical cells induced by N-Methyl-D-aspartate and gp120 of HIV-1,” European Journal of Pharmacology, vol. 288, no. 1, pp. 27–33, 1994. View at Publisher · View at Google Scholar
  21. W. E. G. Müller, F. J. Romero, S. Perović, G. Pergande, and P. Pialoglou, “Protection of flupirtine on β-amyloid-induced apoptosis in neuronal cells in vitro: prevention of amyloid-induced glutathione depletion,” Journal of Neurochemistry, vol. 68, no. 6, pp. 2371–2377, 1997. View at Google Scholar
  22. W. E. G. Müller, A. Maidhof, R. K. Zahn, and W. M. Shannon, “Effect of 9 β D arabinofuranosyladenine on DNA synthesis in vivo,” Cancer Research, vol. 37, no. 7, 1977. View at Google Scholar
  23. L. Sachs, Angewandte Statistik, Springer, Berlin, Germany, 1974.
  24. D. A. Scudiero, R. H. Shoemaker, K. D. Paull et al., “Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines,” Cancer Research, vol. 48, no. 17, pp. 4827–4833, 1988. View at Google Scholar
  25. B. Reiter, M. Lechner, E. Lorbeer, and R. Aichholz, “Isolation and characterization of wax esters in fennel and caraway seed oils by SPE-GC,” HRC Journal of High Resolution Chromatography, vol. 22, no. 9, pp. 514–520, 1999. View at Publisher · View at Google Scholar
  26. D. J. Frost and F. D. Gunstone, “The PMR analysis of non-conjugated alkenoic and alkynoic acids and esters,” Chemistry and Physics of Lipids, vol. 15, no. 1, pp. 53–85, 1975. View at Google Scholar
  27. M. Kates, Techniques of Lipidology, North-Holland, Amsterdam, The Netherlands, 2nd edition, 1986.
  28. L. W. Kutcher, S. R. Beauman, E. I. Gruenstein, M. A. Kaetzel, and J. R. Dedman, “Nuclear CaMKII inhibits neuronal differentiation of PC12 cells without affecting MAPK or CREB activation,” American Journal of Physiology, vol. 284, no. 6, pp. C1334–C1345, 2003. View at Google Scholar
  29. G. Spasovski, S. Gelev, J. Masin-Spasovska, G. Selim, A. Sikole, and R. Vanholder, “Improvement of bone and mineral parameters related to adynamic bone disease by diminishing dialysate calcium,” Bone, vol. 41, no. 4, pp. 698–703, 2007. View at Publisher · View at Google Scholar · View at PubMed
  30. H. Thormar and H. Hilmarsson, “The role of microbicidal lipids in host defense against pathogens and their potential as therapeutic agents,” Chemistry and Physics of Lipids, vol. 150, no. 1, pp. 1–11, 2007. View at Publisher · View at Google Scholar · View at PubMed
  31. A. Slomiany and B. L. Slomiany, “Neutral glyceroglucolipids of the human gastric content,” Biochemical and Biophysical Research Communications, vol. 76, no. 1, pp. 115–120, 1977. View at Google Scholar
  32. C. C. Cheah and I. A. Hansen, “Wax esters in the stomach oil of petrels,” International Journal of Biochemistry, vol. 1, no. 2, pp. 198–202, 1970. View at Google Scholar
  33. M. Tsujimoto and S. Toyama, “Studies on unsaponifiable fractions from some fish liver oil,” Annual Report Tokyo Institute of Technology, vol. 16, pp. 471–510, 1921. View at Google Scholar
  34. F. M. Berger, “Relationship between chemical structure and central depressant action of α-substituted ethers of glycerol,” Journal of Pharmacology and Experimental Therapeutics, vol. 93, pp. 470–481, 1948. View at Google Scholar
  35. F. M. Berger, C. V. Hubbard, and B. J. Ludwig, “Antimicrobial action of certain glycerol ethers and related compounds,” Applied Microbiology, vol. 1, no. 3, pp. 146–149, 1953. View at Google Scholar
  36. A. Emmerie, C. Engel, and W. Klip, “Die tuberkulostatische Wirkung des Unverseifbaren des Dorschleberöles in vitro,” Journal of the Science of Food and Agriculture, vol. 3, p. 264, 1952. View at Google Scholar
  37. A. Brohult, “Alkoxyglycerols as growth-stimulating substances,” Nature, vol. 188, no. 4750, pp. 591–592, 1960. View at Publisher · View at Google Scholar
  38. T. Edlund, “Protective effect of d,l-α-octadecylglycerol-ether in mice given total body X-irradiation,” Nature, vol. 174, no. 4441, p. 1102, 1954. View at Publisher · View at Google Scholar
  39. J. Bodman and J. H. Maisin, “The α-glyceryl ethers,” Clinica Chimica Acta, vol. 3, no. 3, pp. 253–274, 1958. View at Google Scholar
  40. R. G. Burford and C. W. Gowdey, “Anti-inflammatory activity of alkoxyglycerols in rats,” Archives Internationales de Pharmacodynamie et de Therapie, vol. 173, no. 1, pp. 56–70, 1968. View at Google Scholar
  41. K. Ando, K. Kodama, A. Kato, G. Tamura, and K. Arima, “Antitumor activity of glyceryl ethers,” Cancer Research, vol. 32, no. 1, pp. 125–129, 1972. View at Google Scholar
  42. F. Hauss, J. Liu, A. Michelucci et al., “Dual bioactivity of resveratrol fatty alcohols: differentiation of neural stem cells and modulation of neuroinflammation,” Bioorganic and Medicinal Chemistry Letters, vol. 17, no. 15, pp. 4218–4222, 2007. View at Publisher · View at Google Scholar · View at PubMed
  43. M. Bousquet, M. Saint-Pierre, C. Julien, N. Salem Jr., F. Cicchetti, and F. Calon, “Beneficial effects of dietary omega-3 polyunsaturated fatty acid on toxin-induced neuronal degeneration in an animal model of Parkinson's disease,” The FASEB Journal, vol. 22, no. 4, pp. 1213–1225, 2008. View at Publisher · View at Google Scholar · View at PubMed
  44. P. T. Pugliese, K. Jordan, H. Cederberg, and J. Brohult, “Some biological actions of alkylglycerols from shark liver oil,” Journal of Alternative and Complementary Medicine, vol. 4, no. 1, pp. 87–99, 1998. View at Google Scholar
  45. W. E. G. Müller, H. C. Schröder, W. Matthias, P.-O. Sanja, B. Renato, and I. M. Müller, “Traditional and modern biomedical prospecting: part II—the benefits: approaches for a sustainable exploitation of biodiversity (secondary metabolites and biomaterials from sponges),” Evidence-Based Complementary and Alternative Medicine, vol. 1, pp. 133–144, 2004. View at Google Scholar